The National Weather Service issued a report at 9:14 p.m. EDT on Tuesday for strong thunderstorms until 10 p.m. EDT for St.

This month, lenacapavir is expected to receive FDA approval for pre-exposure prophylaxis (PrEP). It could very well be that ...

Gilead Sciences Inc. closed 9.97% short of its 52-week high of $119.96, which the company reached on March 10th.

Using a recent survey on the adoption of AI/ML conducted by the Tufts CSDD as context, pharma leaders discussed how they are using these technologies to optimize trial execution.

In the midst of the nationwide “No Kings” movement on Saturday, dozens of women walked the streets silently in red handmaid’s costumes in Fort Worth holding up the sign “We the people were not meant ...

The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug ...

Lenacapavir, a twice-yearly HIV prevention shot by Gilead, could be produced for $25 a year but may sell for $25K, raising ...

A man who could be facing the death penalty in the death of a Morrow County sheriff’s deputy had his second arraignment ...

In celebration of fathers, the Balm of Gilead Alternative Clinic, in collaboration with the New Tafo PIWC, held the second edition of the Legacy Fathers’ Awards to honour servicemen in Kumasi. The ...

Gilead Sciences Inc. (NASDAQ:GILD) is one of the 12 best healthcare stocks to buy now. Nevertheless, the company suffered a significant setback after the US Food and Drug Administration put on hold ...